During the past decade, Great Lakes Gastroenterology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 15 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Great Lakes Gastroenterology" #1 sponsor was "Pfizer" with 5 trials, followed by "Shire" with 4 trials sponsored, "Celgene" with 3 trials sponsored, "Bausch Health Americas, Inc." with 2 trials sponsored and "Coronado Biosciences, Inc." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Great Lakes Gastroenterology" #1 collaborator was "Parexel" with 2 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Great Lakes Gastroenterology" are "Crohn's Disease" (5 trials), "Crohn Disease" (4 trials), "Eosinophilic Esophagitis (EoE)" (4 trials), "Ulcerative Colitis" (3 trials) and "Chronic Idiopathic Constipation" (2 trials). Many other conditions were trialed in "Great Lakes Gastroenterology" in a lesser frequency.

Most popular intervention types in "Great Lakes Gastroenterology" are "Drug" (21 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "CP-690,550" (4 trials), "Ozanimod" (3 trials), "Oral Budesonide Suspension (OBS)" (2 trials) and "APT-1011 3 mg HS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Great Lakes Gastroenterology" are 23 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Great Lakes Gastroenterology". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Great Lakes Gastroenterology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Great Lakes Gastroenterology, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Great Lakes Gastroenterology has several departments that took part in Clinical trials: "Great Lakes Gastroenterology" - 2 trials